Waters (NYSE:WAT) Receives "Hold (C)" Rating from Weiss Ratings

Key Points

• Waters has been assigned a "hold (C)" rating by Weiss Ratings, reflecting caution amid various market opinions.
• Analysts from Bank of America and JPMorgan Chase recently adjusted their price targets for Waters, setting them at $375.00 and $325.00, respectively, while maintaining neutral ratings.
• Waters' stock recently traded at $358.81, with a 12-month range between $275.05 and $423.56, indicating moderate volatility in its price.

Waters (NYSE:WAT - Get Free Report)'s stock had its "hold (c)" rating reissued by Weiss Ratings in a research note issued on Friday,Weiss Ratings reports.

Several other equities research analysts also recently commented on the company. Bank of America boosted their price objective on Waters from $370.00 to $375.00 and gave the company a "neutral" rating in a report on Thursday, June 26th. Robert W. Baird lowered their price objective on shares of Waters from $374.00 to $352.00 and set an "outperform" rating on the stock in a report on Wednesday, July 16th. Rothschild Redb upgraded shares of Waters to a "strong-buy" rating in a report on Wednesday, October 8th. Wall Street Zen lowered shares of Waters from a "buy" rating to a "hold" rating in a report on Saturday, July 26th. Finally, JPMorgan Chase & Co. lifted their price target on Waters from $300.00 to $325.00 and gave the company a "neutral" rating in a research note on Thursday, October 9th. Two research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $376.80.

Waters Stock Up 0.9%

NYSE WAT traded up $3.13 on Friday, hitting $358.81. 134,554 shares of the company were exchanged, compared to its average volume of 628,203. Waters has a 12 month low of $275.05 and a 12 month high of $423.56. The company has a current ratio of 1.75, a quick ratio of 1.22 and a debt-to-equity ratio of 0.55. The company has a market cap of $21.36 billion, a PE ratio of 32.36, a PEG ratio of 3.24 and a beta of 1.04. The stock has a fifty day moving average of $310.21 and a 200-day moving average of $323.44.

Waters (NYSE:WAT - Get Free Report) last released its quarterly earnings data on Thursday, May 19th. The medical instruments supplier reported $2.29 earnings per share (EPS) for the quarter. Waters had a net margin of 21.71% and a return on equity of 38.60%. The company had revenue of $608.55 million for the quarter. As a group, analysts forecast that Waters will post 12.86 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Olde Wealth Management LLC bought a new stake in shares of Waters during the 1st quarter worth $25,000. Zions Bancorporation National Association UT purchased a new stake in Waters during the first quarter worth about $28,000. IFP Advisors Inc raised its position in Waters by 118.9% in the first quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier's stock worth $30,000 after acquiring an additional 44 shares during the period. Caitong International Asset Management Co. Ltd bought a new stake in Waters in the first quarter worth about $41,000. Finally, CYBER HORNET ETFs LLC purchased a new position in Waters in the second quarter valued at about $53,000. Hedge funds and other institutional investors own 94.01% of the company's stock.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.